Related Experiment Video

Updated: Jun 19, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Potential for therapeutic targeting of tumor stem cells

Vaibhav Saini1, Robert H Shoemaker

  • 1Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, Frederick, Maryland, USA.

Cancer Science
|October 29, 2009
PubMed

Insights

Identifying tumor stem cell (TSC) markers and understanding their resistance mechanisms are key to developing targeted therapies. This review covers TSC markers, isolation technologies, and therapeutic strategies for TSC ablation.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Research

Background:

  • Tumor stem cells (TSCs) are increasingly recognized as critical drivers of tumor growth and therapeutic resistance.
  • Conventional therapies often fail to eradicate TSCs due to their unique biological characteristics and niche interactions.

Purpose of the Study:

  • To review current knowledge on TSC markers and isolation technologies.
  • To discuss the intrinsic properties of TSCs that contribute to therapeutic resistance.
  • To highlight the potential for TSC-targeted therapies.

Main Methods:

  • Literature review of recent advancements in TSC research.
  • Analysis of cell surface, enzymatic, gene expression, and functional markers.
  • Discussion of technologies for TSC identification and isolation.
  • Examination of TSC characteristics (quiescence, drug resistance, DNA repair, anti-apoptosis) and niche factors.

Main Results:

  • Various markers and technologies have been developed for TSC identification and isolation.
  • TSCs possess inherent mechanisms conferring resistance to conventional treatments.
  • Understanding TSC biology provides a foundation for novel therapeutic approaches.

Conclusions:

  • Targeting TSCs holds significant promise for improving cancer treatment outcomes.
  • Further research into TSC-specific pathways and vulnerabilities is crucial for developing effective ablation strategies.
  • The identified markers and resistance mechanisms are essential for designing next-generation cancer therapies.

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.